Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020)

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages

  Milne, R L ^a,b   Fletcher, A S ^a   MacInnis, R J ^a,b   Hodge, A M ^a   Hopkins, A H ^a   Bassett, J K ^a   Bruinsma, F J ^a   Lynch, B M ^a,b,c   Dugue P A ^a,b   Jayasekara, H ^a,b   Brinkman, M T ^a   Popowski, L V ^a   Baglietto, L ^a,b,d,e   Severi, G ^a,b,d,f   O'Dea, K ^a,g   Hopper, J L ^a,b   Southey, M C ^a,b   English, D R ^a,b   Giles, G G ^a,b  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITY OF PISA   (Italy)

^f Human Genetics Foundation   (Italy)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CANCER; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); DIET; HORMONE; PROTEIN; RESEARCH PROGRAM;

ARTICLE; BREAST CANCER; BREAST DENSITY; CANCER RISK; CAUSALITY; COLORECTAL CANCER; DIETARY INTAKE; EPIGENETICS; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HEALTH; HUMAN; LIFESTYLE; MALIGNANT NEOPLASM; NUTRITION; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; ADULT; AGED; AUSTRALIA; CAUCASIAN; COHORT ANALYSIS; DIET; FEMALE; MALE; MIDDLE AGED; MIGRATION; NEOPLASM; NON COMMUNICABLE DISEASE; PROSPECTIVE STUDY;

AUSTRALIA; MELBOURNE; VICTORIA [AUSTRALIA];

ADULT; AGED; AUSTRALIA; COHORT STUDIES; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASMS; NONCOMMUNICABLE DISEASES; PROSPECTIVE STUDIES; RISK FACTORS; TRANSIENTS AND MIGRANTS;

EID: 85034455119     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyx085     Document Type: Article

References (88)

1. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70
2. Riboli E, Hunt KJ, Slimani N et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5:1113-24
3. Doll R, Peto R. The causes of cancer:quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308
4. Australian Bureau of Statistics. Estimated Resident Population by Age and Sex in Statistical Local Areas, Victoria, cat. no. 3207.2. Canberra: Australian Bureau of Statistics, 1993
5. Australian Bureau of Statistics. Estimated Resident Population by Marital Status, Age and Sex, Australia, cat. no. 3220.0. Canberra: Australian Bureau of Statistics, 1992
6. Australian Bureau of Statistics. Estimated Resident Population, by Country of Birth by State, 30 June 1996 to 2011. Canberra: Australian Bureau of Statistics, 2011
7. Ireland P, Jolley D, Giles G et al. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prosepctive study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994;3:19-31
8. Bassett JK, English DR, Fahey MTet al. Validity and calibration of the FFQ used in the Melbourne Collaborative Cohort Study. Public Health Nutr 2016;19:2357-68
9. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11
10. Hodge AM, English DR, O'Dea K et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189-97
11. Key TJ, Appleby PN, Travis RC et al. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr 2015;102:1142-57
12. Hodge AM, Simpson JA, FridmanMet al. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr 2009;12:2438-47
13. Hodge AM, Simpson JA, Gibson RA et al. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 2007;17:415-26
14. Bassett JK, Hodge AM, English DR, MacInnis RJ, Giles GG. Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk. Cancer Causes Control 2016;27:759-73
15. Bassett JK, Severi G, Hodge AM et al. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 2013;133:1882-91
16. Hodge AM, Williamson EJ, Bassett JK, MacInnis RJ, Giles GG, English DR. Dietary and biomarker estimates of fatty acids and risk of colorectal cancer. Int J Cancer 2015;137:1224-34
17. Severi G, Morris HA, MacInnis RJ et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:86-91
18. Baglietto L, Severi G, English DR et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:492-502
19. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:763-68
20. Severi G, Morris HA, MacInnis RJ et al. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1137-41
21. Hodge AM, Jenkins AJ, English DR, O'Dea K, Giles GG. NMRdetermined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract 2009;83:132-39
22. Aung KZ, Robman L, Chong EW, English DR, Giles GG, Guymer RH. Non-mydriatic digital macular photography: how good is the second eye photograph? Ophthalmic Epidemiol 2009;16:254-61
23. Allen KJ, Gurrin LC, Constantine CC et al. Iron-overloadrelated disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221-30
24. Gurrin LC, Osborne NJ, Constantine CC et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008;135:1945-52
25. Zaloumis SG, Allen KJ, Bertalli NA et al. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study. J Gastroenterol Hepatol 2015;30:719-25
26. Amos CI, Dennis J, Wang Z et al. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev 2017;26:126-35
27. Severi G, Southey MC, English DR et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat 2014;148:665-73
28. Dugue PA, Brinkman MT, Milne RL et al. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study. Br J Cancer 2016;115:664-73
29. Fasanelli F, Baglietto L, Ponzi E et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun 2015;6:10192
30. Wong Doo N, Makalic E, Joo JE et al. Global measures of peripheral blood-derived DNA methylation as a risk factor in the development ofmature B-cell neoplasms. Epigenomics 2016;8:55-66
31. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: WCRF/AICR, 1997
32. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: WCRF/AICR, 2007
33. Norat T, Aune D, Chan D, Romaguera D. Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. Cancer Treat Res 2014;159:35-50
34. Hodge AM, English DR, O'Dea K, Giles GG. Dietary patterns and diabetes incidence in the Melbourne Collaborative Cohort Study. Am J Epidemiol 2007;165:603-10
35. Hodge AM, Bassett JK, Shivappa N et al. Dietary inflammatory index, Mediterranean diet score, and lung cancer: a prospective study. Cancer Causes Control 2016;27:907-17
36. Dugue PA, Hodge AM, Brinkman MTet al. Association between selected dietary scores and the risk of urothelial cell carcinoma: A prospective cohort study. Int J Cancer 2016;139:1251-60
37. Baglietto L, Krishnan K, Severi G et al. Dietary patterns and risk of breast cancer. Br J Cancer 2011;104:524-31
38. Hodge AM, O'Dea K, English DR, Giles GG, Flicker L. Dietary patterns as predictors of successful ageing. J Nutr Health Aging 2014;18:221-27
39. Hodge A, Almeida OP, English DR, Giles GG, Flicker L. Patterns of dietary intake and psychological distress in older Australians: benefits not just from a Mediterranean diet. Int Psychogeriatr 2013;25:456-66
40. Harriss LR, English DR, Powles J et al. Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study. Am J Clin Nutr 2007;86:221-29
41. Amirul Islam FM, Chong EW, Hodge AM et al. Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology 2014;121:1428-34 e2
42. Bassett JK, Hodge AM, English DR et al. Dietary intake of B vitamins and methionine and risk of lung cancer. Eur J Clin Nutr 2012;66:182-87
43. Bassett JK, Severi G, Hodge AM et al. Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality. Cancer Causes Control 2012;23:855-63
44. Bassett JK, Severi G, Hodge AM et al. Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr Cancer 2013;65:659-67
45. Wang Y, Davies-Tuck ML, Wluka AE et al. Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort study. Arthritis Res Ther 2009;11:R63
46. Shang X, Sanders KM, Scott D et al. Dietary alpha-linolenic acid and total omega-3 fatty acids are inversely associated with abdominal aortic calcification in older women, but not in older men. J Nutr 2015;145:1778-86
47. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008;126:826-33
48. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:1417-21
49. Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2117-25
50. MacInnis RJ, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control 2006;17:1291-97
51. MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, Giles GG. Body size and composition and colon cancer risk in women. Int J Cancer 2006;118:1496-500
52. MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 2005;97:1154-57
53. MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer 2006;118:2628-31
54. MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004;13:553-59
55. Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR. A comparison of adiposity measures as predictors of all-cause mortality:the Melbourne Collaborative Cohort Study. Obesity (Silver Spring) 2007;15:994-1003
56. Tanamas SK, Ng WL, Backholer K, Hodge A, Zimmet PZ, Peeters A. Quantifying the proportion of deaths due to body mass index-and waist circumference-defined obesity. Obesity (Silver Spring) 2016;24:735-42
57. Wong E, Stevenson C, Backholer K et al. Adiposity measures as predictors of long-term physical disability. Ann Epidemiol 2012;22:710-16
58. Backholer K, Pasupathi K, Wong E, Hodge A, Stevenson C, Peeters A. The relationship between body mass index prior to old age and disability in old age. Int J Obes (Lond) 2012;36: 1180-06
59. MacInnis RJ, Hodge AM, Dixon HG et al. Predictors of increased body weight and waist circumference for middle-aged adults. Public Health Nutr 2014;17:1087-97
60. Karahalios A, Simpson JA, Baglietto L et al. Change in body size and mortality: results from the Melbourne collaborative cohort study. PLoS One 2014;9:e99672
61. Jayasekara H, MacInnis RJ, Williamson EJ et al. Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS-but not BRAF+ colorectal cancer. Int J Cancer 2017;140:1485-93
62. Jayasekara H, MacInnis RJ, Hodge AM et al. Lifetime alcohol consumption and upper aero-digestive tract cancer risk in the Melbourne Collaborative Cohort Study. Cancer Causes Control 2015;26:297-301
63. Jayasekara H, MacInnis RJ, Hodge AM et al. Is breast cancer risk associated with alcohol intake before first full-term pregnancy? Cancer Causes Control 2016;27:1167-74
64. Jayasekara H, MacInnis RJ, Hodge AM et al. Alcohol consumption for different periods in life, intake pattern over time and all-cause mortality. J Public Health (Oxf) 2015;37: 625-33
65. Berrington de Gonzalez A, Hartge P, Cerhan JR et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211-19
66. Eeles RA, Kote-Jarai Z, Giles GG et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-21
67. Michailidou K, Hall P, Gonzalez-Neira A et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353-61, 61e1-2
68. Michailidou K, Beesley J, Lindstrom S et al. Genome-wide association analysis of more than 120, 000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet 2015;47: 373-80
69. Garcia-Closas M, Couch FJ, Lindstrom S et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013;45:392-98, 8e1-2
70. Ghoussaini M, Fletcher O, Michailidou K et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012;44:312-18
71. Easton DF, Pooley KA, Dunning AM et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93
72. Ahmed S, Thomas G, Ghoussaini M et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90
73. Kote-Jarai Z, Easton DF, Stanford JL et al. Multiple novel prostate cancer predisposition loci confirmed by an international study:the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 2008;17:2052-61
74. Eeles RA, Kote-Jarai Z, Al Olama AA et al. Identification of seven new prostate cancer susceptibility loci through a genomewide association study. Nat Genet 2009;41:1116-21
75. Kote-Jarai Z, Olama AA, Giles GG et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011;43:785-91
76. Eeles RA, Olama AA, Benlloch S et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385-91, 91e1-2
77. Al Olama AA, Kote-Jarai Z, Berndt SI et al. A meta-analysis of 87, 040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014;46:1103-09
78. Lindstrom S, Schumacher F, Siddiq A et al. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers-results from BPC3. PLoS One 2011;6:e17142
79. Mavaddat N, Pharoah PD, Michailidou K et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015;107. doi: 10.1093/jnci/djv036
80. Milne RL, Herranz J, Michailidou K et al. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46, 450 cases and 42, 461 controls from the Breast Cancer Association Consortium. Hum Mol Genet 2014;23:1934-46
81. Tsilidis KK, Travis RC, Appleby PN et al. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012;175:926-35
82. Gaudet MM, Barrdahl M, Lindstrom S et al. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat 2016;155:531-40
83. Joshi AD, Lindstrom S, Husing A et al. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2014;180:1018-27
84. Barrdahl M, Canzian F, Joshi AD et al. Post-GWAS geneenvironment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79, 000 women. Hum Mol Genet 2014;23:5260-70
85. Milne RL, Gaudet MM, Spurdle AB et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium:a combined case-control study. Breast Cancer Res 2010;12:R110
86. Wolpin BM, Rizzato C, Kraft P et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet 2014;46:994-1000
87. Sampson JN, WheelerWA, YeagerMet al. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. JNatl Cancer Inst 2015;107:djv279
88. Wang Z, Zhu B, ZhangMet al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet 2014;23:6616-33